Nutra Pharma Announces Laboratory Recertification and Manufacturing Updates
12 nov. 2014 08h30 HE
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Nov 12, 2014) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Retains BUYINS.NET to Surveil Short Sellers and Market-Makers
21 août 2014 08h30 HE
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Aug 21, 2014) - Nutra Pharma Corp (OTC: NPHC)
Approximately 547 Million Shares Shorted Since August 2009
Short...
Nutra Pharma Provides Nyloxin(R) Marketing Updates
19 août 2014 08h00 HE
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Aug 19, 2014) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Announces Nyloxin Television Commercial Rollout
25 juin 2014 10h09 HE
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Jun 25, 2014) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Announces Completion of Commercials by MyNyloxin.com
25 juin 2014 09h23 HE
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Jun 25, 2014) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Announces Contracts for Nyloxin Television Commercials
10 juin 2014 08h00 HE
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Jun 10, 2014) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Announces Completion of Commercials by MyNyloxin.com
28 mai 2014 08h00 HE
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - May 28, 2014) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma to Seek GSA Certification, Will Market Military Strength Nyloxin to Governmental Agencies and the DoD
22 avr. 2014 08h30 HE
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Apr 22, 2014) - Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Announces New Telemarketing and Social Media Campaign Through MyNyloxin.com
03 avr. 2014 08h30 HE
|
Nutra Pharma, Inc.
CORAL SPRINGS, FL--(Marketwired - Apr 3, 2014) - Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Announces the First Shipments and Product Delivery to MyNyloxin.com Independent Entrepreneurs
07 janv. 2014 09h33 HE
|
Nutra Pharma, Inc.
CORAL SPRINGS, FL--(Marketwired - Jan 7, 2014) - Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...